http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021220375-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d36790a0896dda6c7c13aed7764ac2b4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2021-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea7188e0d42b57354432f044e945fc20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5e70a078a5461b1ee98b5fb1ceffe22
publicationDate 2021-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021220375-A1
titleOfInvention Stable ready to use cyclophosphamide liquid formulations
abstract The present invention relates to stable ready to use liquid formulations of Cyclophosphamide for parenteral use. The ready to use composition comprises Cyclophosphamide dissolved in a solvent system comprising a solvent, cosolvent(s) and antioxidant(s).
priorityDate 2015-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10993952-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453578705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID431682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415964816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID476355804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID311895680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12353
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452751444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226596016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3074467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID340271644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411625
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160904981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21335660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414870803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3074468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID522769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232446067

Total number of triples: 59.